Biotech · Private company
Lung Biotechnology PBC
Track this companyFree. Adds Lung Biotechnology PBC to your Dealase workspace and tells you when its record changes.
Clinical trials101 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Beraprost Sodium 314d Modified Release TabletsPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- EsuberaprostPhase 3 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Beraprost Sodium Modified ReleasePhase 2 · Pulmonary Arterial HypertensionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- Porcine Kidney Xenotransplantation in Patients With End-Stage Kidney DiseasePHASE1 · WITHDRAWN · started Jan 31, 2024ClinicalTrials.gov NCT05340426 · fetched Nov 12, 2026
- A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial HypertensionPHASE4 · ACTIVE_NOT_RECRUITING · started Oct 20, 2022ClinicalTrials.gov NCT05203510 · fetched Nov 12, 2026
- Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAHCOMPLETED · started Apr 1, 2019ClinicalTrials.gov NCT03888365 · fetched Nov 12, 2026
- Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)PHASE3 · TERMINATED · started Dec 21, 2018ClinicalTrials.gov NCT03794583 · fetched Nov 12, 2026
- A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial HypertensionPHASE3 · TERMINATED · started Dec 10, 2018ClinicalTrials.gov NCT03657095 · fetched Nov 12, 2026
- Beraprost-314d Added-on to Tyvaso® (BEAT)PHASE3 · COMPLETED · started May 31, 2013ClinicalTrials.gov NCT01908699 · fetched Nov 12, 2026
- Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)PHASE2 · COMPLETED · started Feb 1, 2010ClinicalTrials.gov NCT00989963 · fetched Nov 12, 2026
- Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) PatientsPHASE2 · COMPLETED · started Nov 30, 2009ClinicalTrials.gov NCT00990314 · fetched Nov 12, 2026
- An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) PatientsPHASE2 · COMPLETED · started Feb 28, 2009ClinicalTrials.gov NCT00792571 · fetched Nov 12, 2026
- A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH PatientsPHASE2 · COMPLETED · started Jan 31, 2009ClinicalTrials.gov NCT00781885 · fetched Nov 12, 2026